BlackRock Health Sciences Trust (BME): fair value, margin of safety and Wheel Score

Is BME undervalued?

At 47.79 (close of 5 Nov 2026), BME trades 76% below the GLS average fair value of 197.63. That average comes from 7 models run on the latest filings, and 5 of them land above the current price. Margins of safety over 30% are the exception rather than the rule across the ~7,400 stocks we value each night, so the number earns BlackRock Health Sciences Trust the full Value points in the Wheel Score - and a closer look at what the market is pricing in.

The 7 models disagree widely: DCF gives 4.02 while GLS Growth gives 492.68. A spread that wide means the average is sensitive to which methods you trust; the model table below shows where each one lands, and the Quote page lets you switch any of them off.

Ranked against every other company we cover, neither cheapness nor growth clearly wins for BME, so the nightly engine files it under Blend (value score 83, growth score 88, out of 100). It also carries the Income tag (Income = a dividend yield of 4% or more).

Nine valuation models for BME

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

Quality and financial health

Financial health is weak: BME passes 4 of the nine Piotroski tests. Our scans drop the stock at the health filter; a low score is often the reason a stock looks cheap on the valuation models. The GLS Moat score is low at 4.8 out of 10: returns on capital, margins or the balance sheet have not shown a lasting edge yet - often a young company, a thin-margin business or one that has only recently turned profitable.

Returns on capital are high - ROIC 13.5%, ROE 13.5%, ROA 13.5% - with debt at 0.00 times equity and negative free cash flow.

The dividend yield is high at 6.58% (payout ratio 20%). A yield this size is often the market's way of pricing a risk to the payout, so the health score and cash flow matter more than usual.

Institutional ownership scores 2/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.

Wheel Score 30: No options

BME has no listed options in the nightly snapshot, so there is nothing to sell and the stock cannot be wheeled however good the business. It fails the first Wheel Trade Filter (options that actually trade), so the score stays under 70 and is shown as "No options" (30 here). The valuation and quality numbers still apply to owning the shares outright.

Volume runs at 53k shares a day on a market cap of $618M, with a beta of 0.60 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score rates that fair.

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls: a stock must pass all 9 Wheel Trade Filters to score 70, and the score then ranks the ones that pass; the Sunday Scan is the top 10. It is updated nightly and is not a recommendation. How the Wheel Score works · the walkthrough lesson shows how it fits into a trade, start to finish.

Upcoming events

No upcoming earnings date is recorded for BME in the nightly calendar. The shares go ex-dividend on 13 Nov 2026 (0.2621 per share), so a covered call sold before then carries a small early-assignment risk around that date.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Asset Management

The 12 companies below are the closest to BlackRock Health Sciences Trust by market cap within the Asset Management industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

⚖ Compare BME with 7 of them   All Financial Services stocks →